Berman Capital Advisors’s BioTelemetry, Inc. BEAT Stock Holding History

Berman Capital Advisors’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-148	Closed	-$10K	–	1981
2020 Q4	$10K	Hold	148	–	–	﹤0.01%	939
2020 Q3	$6K	Buy	+148	New	+$6.19K	﹤0.01%	1009
2019 Q2	–	Sell	-15	Closed	–	–	1667
2019 Q1	$0	Buy	+15	New	+$1.03K	﹤0.01%	1568

Other funds holding BEAT

LCM

Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

Berman Capital Advisors's BEAT Position: Q1 2021 in Review

Berman Capital Advisors sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 148 shares — an estimated $10K sold.

Berman Capital Advisors first reported a position in BEAT in Q1 2019 and held it in 3 quarters. The position peaked at $10K in Q4 2020. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

Berman Capital Advisors reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
Berman Capital Advisors sold 148 BioTelemetry, Inc. shares in Q1 2021, an estimated $10K.
Berman Capital Advisors first reported a position in BioTelemetry, Inc. in Q1 2019 and held it in 3 quarters.
Berman Capital Advisors's BioTelemetry, Inc. position peaked at $10K in Q4 2020.
1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on Berman Capital Advisors's 13F filing for Q1 2021, filed 11 May 2021.